Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,092 | 212 | 88.3% |
| Gift | $240.00 | 1 | 6.9% |
| Education | $170.65 | 7 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,157 | 101 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $397.51 | 22 | $0 (2019) |
| Genentech USA, Inc. | $297.10 | 15 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $241.19 | 11 | $0 (2019) |
| Resmed Corp | $240.00 | 1 | $0 (2018) |
| Gilead Sciences Inc | $161.67 | 11 | $0 (2017) |
| Grifols USA, LLC | $152.06 | 10 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $136.89 | 11 | $0 (2019) |
| PFIZER INC. | $91.16 | 5 | $0 (2018) |
| Advanced Respiratory, Inc | $81.06 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $43.64 | 3 | GlaxoSmithKline, LLC. ($43.64) |
| 2021 | $42.19 | 3 | GlaxoSmithKline, LLC. ($42.19) |
| 2019 | $973.07 | 63 | GlaxoSmithKline, LLC. ($275.15) |
| 2018 | $1,353 | 83 | GlaxoSmithKline, LLC. ($414.43) |
| 2017 | $1,092 | 68 | GlaxoSmithKline, LLC. ($381.21) |
All Payment Transactions
220 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/21/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: RESPIRATORY | ||||||
| 02/22/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: RESPIRATORY | ||||||
| 01/24/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: RESPIRATORY | ||||||
| 04/27/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: RESPIRATORY | ||||||
| 03/15/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $1.74 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $3.02 | General |
| Category: RESPIRATORY | ||||||
| 07/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2019 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Cardiology | ||||||
| 07/12/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: RESPIRATORY | ||||||
| 07/11/2019 | ADVANCED RESPIRATORY, INC | The Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Airway Clearance Device | ||||||
| 07/11/2019 | Advanced Respiratory, Inc | The Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $3.68 | General |
| Category: Airway Clearance Device | ||||||
| 07/09/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.33 | General |
| 07/08/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: RESPIRATORY | ||||||
| 07/08/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.25 | General |
| Category: RESPIRATORY | ||||||
| 07/08/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $1.91 | General |
| Category: RESPIRATORY | ||||||
| 07/01/2019 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Cardiology | ||||||
| 06/29/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $3.13 | General |
| Category: RESPIRATORY | ||||||
| 06/28/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $11.23 | General |
| 06/27/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/18/2019 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: RESPIRATORY | ||||||
| 06/17/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 843 | 1,019 | $315,573 | $79,421 |
| 2022 | 13 | 842 | 1,062 | $320,425 | $81,251 |
| 2021 | 13 | 810 | 1,026 | $312,844 | $83,376 |
| 2020 | 15 | 935 | 1,229 | $409,440 | $100,155 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 187 | $63,580 | $17,245 | 27.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 188 | 258 | $59,340 | $15,887 | 26.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 71 | 110 | $36,410 | $10,687 | 29.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 62 | 62 | $41,106 | $9,901 | 24.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 55 | 58 | $37,816 | $8,093 | 21.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 68 | 96 | $22,080 | $6,151 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $18,725 | $4,376 | 23.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 16 | $7,152 | $1,671 | 23.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 38 | 38 | $7,600 | $1,146 | 15.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 24 | 24 | $4,560 | $1,046 | 22.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 35 | 36 | $3,600 | $844.44 | 23.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 38 | 41 | $4,797 | $823.46 | 17.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 23 | 23 | $3,220 | $803.85 | 25.0% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 18 | 18 | $5,094 | $632.34 | 12.4% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 17 | 17 | $493.00 | $112.20 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 161 | 204 | $69,360 | $20,265 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 211 | 270 | $62,100 | $16,791 | 27.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 65 | 114 | $37,734 | $9,426 | 25.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 56 | 57 | $37,164 | $8,426 | 22.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 65 | 118 | $27,140 | $6,821 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $24,610 | $5,877 | 23.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 37 | 37 | $24,531 | $5,859 | 23.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 19 | $8,493 | $1,900 | 22.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 32 | 35 | $6,634 | $1,547 | 23.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 39 | 41 | $8,200 | $1,246 | 15.2% |
About Dr. Steven Gittler, MD
Dr. Steven Gittler, MD is a Pulmonary Disease healthcare provider based in Hollywood, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730176728.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Gittler, MD has received a total of $3,503 in payments from pharmaceutical and medical device companies, with $43.64 received in 2022. These payments were reported across 220 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,092).
As a Medicare-enrolled provider, Gittler has provided services to 3,430 Medicare beneficiaries, totaling 4,336 services with total Medicare billing of $344,203. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Hollywood, FL
- Active Since 10/04/2005
- Last Updated 03/15/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1730176728
Products in Payments
- ANORO (Drug) $450.27
- TRELEGY ELLIPTA (Drug) $288.07
- AirSense (Device) $240.00
- BREO (Drug) $228.87
- Xolair (Biological) $173.55
- SYMBICORT (Drug) $167.46
- NUCALA (Biological) $163.68
- Esbriet (Biological) $123.55
- Prolastin-C (Biological) $111.72
- OFEV (Drug) $111.32
- FASENRA (Drug) $93.01
- BEVESPI AEROSPHERE (Drug) $91.62
- The Vest System Model 105 Home Care (Device) $81.06
- DUPIXENT (Biological) $75.59
- XOLAIR (Biological) $72.66
- CHANTIX (Drug) $71.54
- STIOLTO RESPIMAT (Drug) $65.78
- UPTRAVI (Drug) $60.86
- Adempas (Drug) $58.43
- UTIBRON (Drug) $53.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Hollywood
Dr. Howard Braver, M.d, M.D
Pulmonary Disease — Payments: $16,119
Brian Gotkin, Md, MD
Pulmonary Disease — Payments: $10,604
Jyoti Shah
Pulmonary Disease — Payments: $4,537
Boris Betancourt, Md, MD
Pulmonary Disease — Payments: $1,342
Ronald Gup, M.d, M.D
Pulmonary Disease — Payments: $887.58
Sheyla Paredes Aller, Md, MD
Pulmonary Disease — Payments: $276.37